O	0	3	p75	p75	NN	B-NP
O	4	12	mediated	mediate	VBD	B-VP
O	13	22	apoptosis	apoptosis	NN	B-NP
O	23	25	in	in	IN	B-PP
B-Cell	26	39	neuroblastoma	neuroblastoma	NN	B-NP
I-Cell	40	45	cells	cell	NNS	I-NP
O	46	48	is	be	VBZ	B-VP
O	49	58	inhibited	inhibit	VBN	I-VP
O	59	61	by	by	IN	B-PP
O	62	72	expression	expression	NN	B-NP
O	73	75	of	of	IN	B-PP
O	76	80	TrkA	TrkA	NN	B-NP
O	80	81	.	.	.	O

O	83	93	BACKGROUND	BACKGROUND	NN	B-NP
O	93	94	:	:	:	O
O	95	108	Neurotrophins	Neurotrophin	NNS	B-NP
O	109	116	mediate	mediate	VBP	B-VP
O	117	122	their	their	PRP$	B-NP
O	123	130	effects	effect	NNS	I-NP
O	131	133	by	by	IN	B-PP
O	134	141	binding	bind	VBG	B-VP
O	142	144	to	to	TO	B-PP
O	145	152	members	member	NNS	B-NP
O	153	155	of	of	IN	B-PP
O	156	159	the	the	DT	B-NP
O	160	163	Trk	Trk	NN	I-NP
O	164	170	family	family	NN	I-NP
O	171	173	of	of	IN	B-PP
O	174	182	receptor	receptor	NN	B-NP
O	183	191	tyrosine	tyrosine	NN	I-NP
O	192	199	kinases	kinase	NNS	I-NP
O	200	203	and	and	CC	B-PP
O	204	206	to	to	TO	B-PP
O	207	210	the	the	DT	B-NP
O	211	214	low	low	JJ	I-NP
O	214	215	-	-	HYPH	I-NP
O	215	223	affinity	affinity	NN	I-NP
O	224	229	nerve	nerve	NN	I-NP
O	230	236	growth	growth	NN	I-NP
O	237	243	factor	factor	NN	I-NP
O	244	252	receptor	receptor	NN	I-NP
O	253	256	p75	p75	NN	I-NP
O	256	257	.	.	.	O

O	258	263	Nerve	Nerve	NN	B-NP
O	264	270	growth	growth	NN	I-NP
O	271	277	factor	factor	NN	I-NP
O	278	279	(	(	(	O
O	279	282	NGF	NGF	NN	B-NP
O	282	283	)	)	)	O
O	284	287	has	have	VBZ	B-VP
O	288	292	been	be	VBN	I-VP
O	293	305	demonstrated	demonstrate	VBN	I-VP
O	306	308	to	to	TO	I-VP
O	309	316	support	support	VB	I-VP
O	317	325	survival	survival	NN	B-NP
O	326	329	and	and	CC	I-NP
O	330	345	differentiation	differentiation	NN	I-NP
O	346	348	of	of	IN	B-PP
B-Cell	349	362	neuroblastoma	neuroblastoma	NN	B-NP
I-Cell	363	364	(	(	(	O
I-Cell	364	366	NB	NB	NN	B-NP
I-Cell	366	367	)	)	)	O
I-Cell	368	373	cells	cell	NNS	B-NP
O	374	376	by	by	IN	B-PP
O	377	387	activation	activation	NN	B-NP
O	388	390	of	of	IN	B-PP
O	391	394	the	the	DT	B-NP
O	395	399	TrkA	TrkA	NN	I-NP
O	400	408	receptor	receptor	NN	I-NP
O	408	409	.	.	.	O

O	410	413	The	The	DT	B-NP
O	414	417	p75	p75	NN	I-NP
O	418	426	receptor	receptor	NN	I-NP
O	427	434	belongs	belong	VBZ	B-VP
O	435	437	to	to	TO	B-PP
O	438	441	the	the	DT	B-NP
O	442	447	tumor	tumor	NN	I-NP
O	448	456	necrosis	necrosis	NN	I-NP
O	457	463	factor	factor	NN	I-NP
O	464	465	(	(	(	O
O	465	468	TNF	TNF	NN	B-NP
O	468	469	)	)	)	O
O	470	476	family	family	NN	B-NP
O	477	479	of	of	IN	B-PP
O	480	485	death	death	NN	B-NP
O	486	495	receptors	receptor	NNS	I-NP
O	496	499	and	and	CC	O
O	500	503	has	have	VBZ	B-VP
O	504	508	been	be	VBN	I-VP
O	509	518	suggested	suggest	VBN	I-VP
O	519	521	as	as	IN	B-PP
O	522	523	a	a	DT	B-NP
O	524	532	receptor	receptor	NN	I-NP
O	533	537	that	that	WDT	B-NP
O	538	546	mediates	mediate	VBZ	B-VP
O	547	556	apoptosis	apoptosis	NN	B-NP
O	557	559	in	in	IN	B-PP
B-Cell	560	568	neuronal	neuronal	JJ	B-NP
O	569	572	and	and	CC	I-NP
B-Cell	573	575	NB	NB	NN	I-NP
I-Cell	576	581	cells	cell	NNS	I-NP
O	581	582	.	.	.	O

O	583	592	PROCEDURE	PROCEDURE	NN	B-NP
O	592	593	:	:	:	O
O	594	596	To	To	TO	B-VP
O	597	608	investigate	investigate	VB	I-VP
O	609	612	the	the	DT	B-NP
O	613	619	effect	effect	NN	I-NP
O	620	622	of	of	IN	B-PP
O	623	626	p75	p75	NN	B-NP
O	627	637	expression	expression	NN	I-NP
O	638	640	in	in	IN	B-PP
B-Cancer	641	643	NB	NB	NN	B-NP
O	643	644	,	,	,	O
O	645	647	we	we	PRP	B-NP
O	648	659	transfected	transfecte	VBD	B-VP
O	660	663	the	the	DT	B-NP
O	664	667	p75	p75	NN	I-NP
O	668	672	cDNA	cDNA	NN	I-NP
O	673	677	into	into	IN	B-PP
B-Cell	678	680	SH	SH	NN	B-NP
I-Cell	680	681	-	-	HYPH	B-NP
I-Cell	681	685	SY5Y	SY5Y	NN	I-NP
I-Cell	686	691	cells	cell	NNS	I-NP
O	691	692	,	,	,	O
O	693	695	an	an	DT	B-NP
B-Cell	696	698	NB	NB	NN	I-NP
I-Cell	699	703	cell	cell	NN	I-NP
I-Cell	704	708	line	line	NN	I-NP
O	709	716	lacking	lack	VBG	B-VP
O	717	727	expression	expression	NN	B-NP
O	728	730	of	of	IN	B-PP
O	731	735	both	both	CC	O
O	736	739	p75	p75	NN	B-NP
O	740	743	and	and	CC	O
O	744	748	TrkA	TrkA	NN	B-NP
O	748	749	.	.	.	O

O	750	757	RESULTS	RESULTS	NNS	B-NP
O	757	758	:	:	:	O
B-Cell	759	763	Cell	Cell	NN	B-NP
I-Cell	764	770	clones	clone	NNS	I-NP
O	771	781	expressing	express	VBG	B-VP
O	782	790	elevated	elevated	JJ	B-NP
O	791	797	levels	level	NNS	I-NP
O	798	800	of	of	IN	B-PP
O	801	804	p75	p75	NN	B-NP
O	805	811	showed	show	VBD	B-VP
O	812	813	a	a	DT	B-NP
O	814	818	high	high	JJ	I-NP
O	819	825	degree	degree	NN	I-NP
O	826	828	of	of	IN	B-PP
O	829	838	apoptosis	apoptosis	NN	B-NP
O	839	843	even	even	RB	B-ADVP
O	844	846	in	in	IN	B-PP
O	847	849	10	10	CD	B-NP
O	849	850	%	%	NN	I-NP
B-Organism_substance	851	856	serum	serum	NN	I-NP
O	856	857	-	-	HYPH	B-VP
O	857	869	supplemented	supplement	VBN	B-NP
O	870	876	medium	medium	NN	I-NP
O	876	877	.	.	.	O

O	878	887	Apoptotic	Apoptotic	JJ	B-NP
O	888	897	signaling	signaling	NN	I-NP
O	898	900	by	by	IN	B-PP
O	901	904	p75	p75	NN	B-NP
O	905	908	was	be	VBD	B-VP
O	909	915	ligand	ligand	NN	B-NP
O	915	916	-	-	HYPH	O
O	916	927	independent	independent	JJ	B-ADJP
O	928	931	and	and	CC	O
O	932	936	only	only	RB	B-NP
O	937	943	partly	partly	RB	I-NP
O	944	951	caspase	caspase	NN	I-NP
O	951	952	-	-	HYPH	I-ADJP
O	952	961	dependent	dependent	JJ	B-ADJP
O	961	962	.	.	.	O

O	963	966	The	The	DT	B-NP
O	967	972	level	level	NN	I-NP
O	973	975	of	of	IN	B-PP
O	976	985	apoptosis	apoptosis	NN	B-NP
O	986	996	correlated	correlate	VBD	B-VP
O	997	1005	directly	directly	RB	B-ADVP
O	1006	1010	with	with	IN	B-PP
O	1011	1014	the	the	DT	B-NP
O	1015	1025	expression	expression	NN	I-NP
O	1026	1031	level	level	NN	I-NP
O	1032	1034	of	of	IN	B-PP
O	1035	1038	the	the	DT	B-NP
O	1039	1047	receptor	receptor	NN	I-NP
O	1047	1048	,	,	,	O
O	1049	1059	indicating	indicate	VBG	B-VP
O	1060	1064	that	that	IN	B-SBAR
O	1065	1068	p75	p75	NN	B-NP
O	1069	1072	may	may	MD	B-VP
O	1073	1081	activate	activate	VB	I-VP
O	1082	1085	the	the	DT	B-NP
B-Cell	1086	1090	cell	cell	NN	I-NP
O	1091	1096	death	death	NN	I-NP
O	1097	1104	program	program	NN	I-NP
O	1105	1113	directly	directly	RB	B-ADVP
O	1113	1114	.	.	.	O

O	1115	1122	However	However	RB	B-ADVP
O	1122	1123	,	,	,	O
O	1124	1134	additional	additional	JJ	B-NP
O	1135	1147	transfection	transfection	NN	I-NP
O	1148	1150	of	of	IN	B-PP
O	1151	1155	TrkA	TrkA	NN	B-NP
O	1156	1160	into	into	IN	B-PP
B-Cell	1161	1165	SY5Y	SY5Y	NN	B-NP
I-Cell	1165	1166	-	-	HYPH	B-NP
I-Cell	1166	1169	p75	p75	NN	I-NP
I-Cell	1170	1175	cells	cell	NNS	I-NP
O	1176	1184	resulted	result	VBD	B-VP
O	1185	1187	in	in	IN	B-PP
O	1188	1189	a	a	DT	B-NP
O	1190	1203	significantly	significantly	RB	I-NP
O	1204	1211	reduced	reduce	VBN	I-NP
O	1212	1216	rate	rate	NN	I-NP
O	1217	1219	of	of	IN	B-PP
O	1220	1229	apoptosis	apoptosis	NN	B-NP
O	1230	1234	even	even	RB	B-ADVP
O	1235	1237	in	in	IN	B-PP
O	1238	1241	the	the	DT	B-NP
O	1242	1249	absence	absence	NN	I-NP
O	1250	1252	of	of	IN	B-PP
O	1253	1256	NGF	NGF	NN	B-NP
O	1256	1257	.	.	.	O

O	1258	1269	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1269	1270	:	:	:	O
O	1271	1275	Thus	Thus	RB	B-ADVP
O	1275	1276	,	,	,	O
O	1277	1287	expression	expression	NN	B-NP
O	1288	1290	of	of	IN	B-PP
O	1291	1294	the	the	DT	B-NP
O	1295	1299	TrkA	TrkA	NN	I-NP
O	1300	1308	receptor	receptor	NN	I-NP
O	1309	1315	itself	itself	PRP	B-NP
O	1316	1324	inhibits	inhibit	VBZ	B-VP
O	1325	1328	p75	p75	NN	B-NP
O	1329	1337	mediated	mediate	VBN	I-NP
O	1338	1347	apoptosis	apoptosis	NN	I-NP
O	1348	1350	in	in	IN	B-PP
B-Cell	1351	1353	NB	NB	NN	B-NP
I-Cell	1354	1359	cells	cell	NNS	I-NP
O	1359	1360	.	.	.	O

